Department of Pharmacology and Pathology, Ziauddin Medical University, Karachi, Pakistan.
Phytother Res. 2010 Jun;24 Suppl 2:S229-32. doi: 10.1002/ptr.3089.
The effects of aqueous-methanol extract of Saussurea lappa Clarke root (Sl.Cr) was investigated against D-galactosamine (D-GalN) and lipopolysaccharide (LPS)-induced hepatitis in mice. Co-administration of D-GalN (700 mg/kg) and LPS (1 microg/kg) significantly raised the plasma transaminase levels (ALT/AST) as compared to the control group (p < 0.05). Pretreatment of mice with different doses of Sl.Cr (150, 300 and 600 mg/kg) significantly prevented the D-GalN and LPS-induced rise in plasma levels of ALT and AST in a dose-dependent manner (p < 0.05). Post-treatment with Sl.Cr (600 mg/kg) significantly restricted the progression of hepatic damage induced by D-GalN and LPS (p < 0.05). The improvement in plasma enzyme levels was further verified by histopathology of the liver, which showed improved architecture, absence of parenchyma congestion, decreased cellular swelling and apoptotic cells in treatment groups as compared to the toxin group of animals. These data indicate that the Sl.Cr exhibits hepatoprotective effect in mice and this study rationalize the traditional use of this plant in liver disorders.
水提甲醇法提取的新疆雪莲花根(Sl.Cr)对 D-半乳糖胺(D-GalN)和脂多糖(LPS)诱导的小鼠肝炎的作用进行了研究。与对照组相比,D-GalN(700mg/kg)和 LPS(1μg/kg)联合给药显著提高了血浆转氨酶水平(ALT/AST)(p<0.05)。用不同剂量的 Sl.Cr(150、300 和 600mg/kg)预处理小鼠可显著地以剂量依赖性方式预防 D-GalN 和 LPS 诱导的血浆 ALT 和 AST 水平升高(p<0.05)。Sl.Cr(600mg/kg)的后期治疗显著限制了 D-GalN 和 LPS 诱导的肝损伤的进展(p<0.05)。血浆酶水平的改善通过肝脏组织病理学进一步得到验证,与毒素组动物相比,治疗组的组织结构得到改善,实质充血减少,细胞肿胀和凋亡细胞减少。这些数据表明,Sl.Cr 在小鼠中表现出肝保护作用,本研究合理化了该植物在肝脏疾病中的传统用途。